ARCHIVES

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

New Law Allows Texans To Self-Refer To M.D. Anderson

December 1, 1995

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989

NCI advisory Group, Other Cancer Meetings

March 29, 1985

ORI Says COMS Study Coordinator Committed Scientific Misconduct

April 12, 1996

In Brief: Radiation Therapy Pioneer Juan Del Regato Dead At 90

July 16, 1999

Surgeons Responsible For Improving Their Role, CCIRC Says

July 8, 1977